Arcadia Biosciences Cash Flow - Annual (NASDAQ:RKDA)

Add to My Stocks
$1.7 $0.01 (0.58%) RKDA stock closing price Oct 21, 2016 (Closing)

The Arcadia Biosciences cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Arcadia Biosciences profits and Arcadia Biosciences debt. Arcadia Biosciences issued $35.72M worth of RKDA shares. The cash flow statement helps in the Arcadia Biosciences stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Arcadia Biosciences has a positive cash and cash equivalents change of $7.4M. View details of Arcadia Biosciences cash flows for latest & last ten financial years.

show more
Get Cash flow for another ticker
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow0.37M0.35M0.39M
Net Increase (Decrease) in Assets Liabilities-0.05M-1.33M-0.14M
Cash From (used in) Discontinued Operations---
Other Adjustments Net2.52M4.53M3.2M
Arcadia Biosciences Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.14M-0.14M-0.1M
Acquisition Disposition of Subsidiaires--1.45M-0.5M
Increase (Decrease) in Investments-46.21M--
Other Cash Inflow (Outflow) from Investment Activities---
Arcadia Biosciences Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares68.58M32.86M0.01M
Issuance (Repayment) of Debt Securities10.2M-1.15M7.83M
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities
Arcadia Biosciences Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---
Arcadia Biosciences Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M
Cash & Equivalents at Year End23.97M16.57M2.83M
All figures in USD. M: Millions of USD, B: Billions of USD.

While Arcadia Biosciences stock price history provides the price history of a stock, Arcadia Biosciences stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Arcadia Biosciences saw a decrease in Net Change in Cash and Cash Equivalents from $13.73M in 2014 to $7.4M in 2015. Apart from the Arcadia Biosciences stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Arcadia Biosciences reported a negative operating cash flow of $-15.1M for 2015 and has seen a decrease from the previous year. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $-46.36M for RKDA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $68.87M for Arcadia Biosciences.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin